Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03294109 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Abdominal Wall Block With Liposomal Bupivacaine for Post-Operative Analgesia in Donor Nephrectomy
A Phase 4 study of Pain, Postoperative and Patient Satisfaction, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 4
- Development phase
- 146
- Enrollment target
- 1
- Study location
NCT03294109: Completed Phase 4 study of Pain, Postoperative and Patient Satisfaction, sponsored by University of California, Los Angeles.
NCT03294109 is a Phase 4 study of Pain, Postoperative and Patient Satisfaction that has completed, run by University of California, Los Angeles. The registered enrollment target is 146 participants, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03294109, a Phase 4 study of Pain, Postoperative and Patient Satisfaction, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 146 participants
- Enrollment target
- 1
- Study location
Study Summary
A blinded randomized control trial in living kidney donors. The study group will receive a liposomal bupivacaine Trans Quadratus Lumborum (TQL) block after the induction of general anesthesia. The following study variables will be collected postoperatively following arrival in the post-anesthesia care unit. Current and maximum intensity pain scores will be documented by nurses in Electronic Health Record (EHR). Total opiate dose consumed every 24 hours will be collected from the EHR and pain diary after discharge. Patient satisfaction will be evaluated using the Revised American Pain Society Patient Outcome Questionnaire (APS-POQ-R) 24 hours' post-procedure. Incidence of nausea will be extracted from nursing notes.
Primary Outcome
Visual Analog Score (VAS) for pain, scores range from 0-10, with lower scores indicating lower pain level
Conditions Studied
Interventions
- DRUG Abdominal wall block with liposomal bupivicaine
Study Locations (1)
California
- Connie Frank Kidney Transplant Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2020-06-24 |
| Phase | Phase 4 |
What the finished NCT03294109 record still lists
NCT03294109 is an interventional study that assigns participants to a tested intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (46% lower).
The record links to 8 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 1 intervention - of which Abdominal wall block with liposomal bupivicaine is the first listed.
NCT03294109 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03294109 about?
NCT03294109 is a clinical study titled "Evaluation of Abdominal Wall Block With Liposomal Bupivacaine for Post-Operative Analgesia in Donor Nephrectomy". A blinded randomized control trial in living kidney donors. The study group will receive a liposomal bupivacaine Trans Quadratus Lumborum (TQL) block after the induction of general anesthesia. The following study variables will be collected postoperatively following arrival in the post-anesthesia ca...
What is the current status of trial NCT03294109?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 146 participants. The study started on 2018-01-01. Estimated completion is 2020-06-24.
What conditions does trial NCT03294109 study?
This clinical trial studies the following conditions: Pain, Postoperative, Patient Satisfaction, Physiological Effects of Drugs, Analgesics, Opioid, Peripheral Nervous System Agents.
What interventions are being tested in trial NCT03294109?
The interventions under investigation include: Abdominal wall block with liposomal bupivicaine (DRUG).
Who is sponsoring clinical trial NCT03294109?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03294109 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03294109's enrollment target sits among peer trials
146 30th of 113 higher than 84 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Management of Postoperative Discomfort in Young Children Following Dental Rehabilitation Under General Anesthesia
RECRUITING · Phase 4
-
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
RECRUITING · Phase 4
-
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
RECRUITING · Phase 4
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
RECRUITING · Phase 4
-
IPACK on Early Pain Scores After ACL Reconstruction
RECRUITING · Phase 4
-
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03490929 · 146 participants · Phase 4
CEUS for Blunt Abdominal Trauma in Children
- NCT04755062 · 146 participants · NA
A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- NCT04867954 · 146 participants
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
- NCT05051618 · 146 participants · NA
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI